83 related articles for article (PubMed ID: 28847033)
1. Epigenetics in Liver Fibrosis.
Massey V; Cabezas J; Bataller R
Semin Liver Dis; 2017 Aug; 37(3):219-230. PubMed ID: 28847033
[No Abstract] [Full Text] [Related]
2. Suv39h1: Targeting epigenetics to treat liver fibrosis.
Papavassiliou KA; Papavassiliou AG
J Cell Mol Med; 2024 Jun; 28(11):e18479. PubMed ID: 38822456
[No Abstract] [Full Text] [Related]
3. Making Sense of Epigenetics.
Schuebel K; Gitik M; Domschke K; Goldman D
Int J Neuropsychopharmacol; 2016 Nov; 19(11):. PubMed ID: 27312741
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial quality control in liver fibrosis: Epigenetic hallmarks and therapeutic strategies.
Jia L; Yang Y; Sun F; Tao H; Lu C; Yang JJ
Cell Signal; 2024 Mar; 115():111035. PubMed ID: 38182067
[TBL] [Abstract][Full Text] [Related]
5. Identifying New Epigenetic Drivers of Liver Fibrosis.
Argemi J; Bataller R
Cell Mol Gastroenterol Hepatol; 2019; 7(1):237-238. PubMed ID: 30539791
[No Abstract] [Full Text] [Related]
6. Molecular and cellular mechanisms of liver fibrosis and its regression.
Kisseleva T; Brenner D
Nat Rev Gastroenterol Hepatol; 2021 Mar; 18(3):151-166. PubMed ID: 33128017
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology.
Chang ML; Yang SS
Cells; 2019 Nov; 8(11):. PubMed ID: 31726658
[TBL] [Abstract][Full Text] [Related]
8. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues.
Parola M; Pinzani M
Mol Aspects Med; 2019 Feb; 65():37-55. PubMed ID: 30213667
[TBL] [Abstract][Full Text] [Related]
9. Schizandrin C regulates lipid metabolism and inflammation in liver fibrosis by NF-κB and p38/ERK MAPK signaling pathways.
Chen P; Wang R; Liu F; Li S; Gu Y; Wang L; Yuan Y
Front Pharmacol; 2023; 14():1092151. PubMed ID: 37288106
[TBL] [Abstract][Full Text] [Related]
10. Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review.
Odriozola A; Santos-Laso A; Del Barrio M; Cabezas J; Iruzubieta P; Arias-Loste MT; Rivas C; Duque JCR; Antón Á; Fábrega E; Crespo J
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175497
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis.
Garbuzenko DV
World J Clin Cases; 2022 Apr; 10(12):3662-3676. PubMed ID: 35647163
[TBL] [Abstract][Full Text] [Related]
12. Clinical, histological and molecular profiling of different stages of alcohol-related liver disease.
Ventura-Cots M; Argemi J; Jones PD; Lackner C; El Hag M; Abraldes JG; Alvarado E; Clemente A; Ravi S; Alves A; Alboraie M; Altamirano J; Barace S; Bosques F; Brown R; Caballeria J; Cabezas J; Carvalhana S; Cortez-Pinto H; Costa A; Degré D; Fernandez-Carrillo C; Ganne-Carrie N; Garcia-Tsao G; Genesca J; Koskinas J; Lanthier N; Louvet A; Lozano JJ; Lucey MR; Masson S; Mathurin P; Mendez-Sanchez N; Miquel R; Moreno C; Mounajjed T; Odena G; Kim W; Sancho-Bru P; Warren Sands R; Szafranska J; Verset L; Schnabl B; Sempoux C; Shah V; Shawcross DL; Stauber RE; Straub BK; Verna E; Tiniakos D; Trépo E; Vargas V; Villanueva C; Woosley JT; Ziol M; Mueller S; Stärkel P; Bataller R
Gut; 2022 Sep; 71(9):1856-1866. PubMed ID: 34992134
[TBL] [Abstract][Full Text] [Related]
13. Cell-specific epigenetic changes in atherosclerosis.
Khan AW; Paneni F; Jandeleit-Dahm KAM
Clin Sci (Lond); 2021 May; 135(9):1165-1187. PubMed ID: 33988232
[TBL] [Abstract][Full Text] [Related]
14. Suberoylanilide Hydroxamic Acid (SAHA) Reduces Fibrosis Markers and Deactivates Human Stellate Cells via the Epithelial-Mesenchymal Transition (EMT).
Özel M; Baskol M; Akalın H; Baskol G
Cell Biochem Biophys; 2021 Jun; 79(2):349-357. PubMed ID: 33689126
[TBL] [Abstract][Full Text] [Related]
15. DNA Methylation Profiling of Human Hepatocarcinogenesis.
Hernandez-Meza G; von Felden J; Gonzalez-Kozlova EE; Garcia-Lezana T; Peix J; Portela A; Craig AJ; Sayols S; Schwartz M; Losic B; Mazzaferro V; Esteller M; Llovet JM; Villanueva A
Hepatology; 2021 Jul; 74(1):183-199. PubMed ID: 33237575
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?
Claveria-Cabello A; Colyn L; Arechederra M; Urman JM; Berasain C; Avila MA; Fernandez-Barrena MG
Cells; 2020 Oct; 9(10):. PubMed ID: 33086678
[TBL] [Abstract][Full Text] [Related]
17. Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300.
Williams LM; McCann FE; Cabrita MA; Layton T; Cribbs A; Knezevic B; Fang H; Knight J; Zhang M; Fischer R; Bonham S; Steenbeek LM; Yang N; Sood M; Bainbridge C; Warwick D; Harry L; Davidson D; Xie W; Sundstrӧm M; Feldmann M; Nanchahal J
Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20753-20763. PubMed ID: 32759223
[TBL] [Abstract][Full Text] [Related]
18. Hydralazine Sensitizes to the Antifibrotic Effect of 5-Aza-2'-deoxycytidine in Hepatic Stellate Cells.
Asada K; Kaji K; Sato S; Seki K; Shimozato N; Kawaratani H; Takaya H; Sawada Y; Nakanishi K; Furukawa M; Kitade M; Moriya K; Namisaki T; Noguchi R; Akahane T; Yoshiji H
Biology (Basel); 2020 Jun; 9(6):. PubMed ID: 32503264
[TBL] [Abstract][Full Text] [Related]
19. TIM-4 interference in Kupffer cells against CCL4-induced liver fibrosis by mediating Akt1/Mitophagy signalling pathway.
Wu H; Chen G; Wang J; Deng M; Yuan F; Gong J
Cell Prolif; 2020 Jan; 53(1):e12731. PubMed ID: 31755616
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Mechanisms of Pancreatobiliary Fibrosis.
Aseem SO; Huebert RC
Curr Treat Options Gastroenterol; 2019 Sep; 17(3):342-356. PubMed ID: 31300946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
